BioXcel Therapeutics to announce phase 3 trial results for agitation treatment
Tweet Send to a Friend
BioXcel Therapeutics Inc. (NASDAQ: BTAI) will host a conference call at 8 a.m. ET on August 27, 2025, to review ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
